Insider trades
Michael Geffner, Chief Officer of Immunovant IMVT, has filed 0 purchases and 12 sales on the open market. Over the past 12 months that comes to a net sale of $70.1K. The latest trade was on 25/10/22.
Michael Geffner
Chief Medical Officer
- Company
- Immunovant IMVT
- First filing
- 24/01/29
- Trades
- 16 trades
- Buys / sales
- 0 / 12
- 12-month net buying
- −$70.1K
- Last trade
- 25/10/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ImmunovantIMVT | Open-market sale | 25/10/22 | 25/10/24 | 2,595 sh | $19.03 | $49,382.85 | −1.2% |
ImmunovantIMVT | Open-market sale | 25/10/08 | 25/10/10 | 1,272 sh | $16.30 | $20,733.6 | −0.6% |
ImmunovantIMVT | Open-market sale | 25/07/23 | 25/07/25 | 2,385 sh | $18.15 | $43,287.75 | −1.1% |
ImmunovantIMVT | Open-market sale | 25/07/09 | 25/07/11 | 1,160 sh | $17.24 | $19,998.4 | −0.5% |
ImmunovantIMVT | Open-market sale | 25/04/23 | 25/04/25 | 2,349 sh | $14.79 | $34,741.71 | −1.0% |
ImmunovantIMVT | Open-market sale | 25/04/09 | 25/04/11 | 6,169 sh | $12.99 | $80,135.31 | −2.6% |
ImmunovantIMVT | Open-market sale | 25/01/22 | 25/01/24 | 2,657 sh | $23.59 | $62,678.63 | −2.0% |
ImmunovantIMVT | Open-market sale | 24/10/23 | 24/10/25 | 3,189 sh | $29.53 | $94,171.17 | −2.3% |
ImmunovantIMVT | Open-market sale | 24/07/24 | 24/07/26 | 3,456 sh | $27.76 | $95,938.56 | −2.4% |
ImmunovantIMVT | Open-market sale | 24/04/24 | 24/04/26 | 3,261 sh | $28.90 | $94,242.9 | −2.3% |
IMVT | Open-market sale | 24/01/26 | 24/01/29 | 10,101 sh2 trades | $37.92avg. | $383,011.53 | −10.1% |